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104Objectives: Leaflet resection represents the reference standard for mitral valve regurgitation. However, the
resection technique is irreversible and requires leaflet cutting and reapproximation. Folding mitral valve repair
is a nonresectional technique with inversion of the prolapsed segment into the left ventricle. The present study
evaluated the effectiveness of this technique.
Methods: The prolapsed segment was inverted into the left ventricle vertically. A pilot suture was placed at the
free edge of the leaflet. After confirming no mitral valve regurgitation with a pressure test, additional sutures
were placed toward the annulus. If the test still showed mitral valve regurgitation, the suture was removed
and repositioned. Ring annuloplasty was performed in all patients, except those with active infectious endocar-
ditis. The repaired mitral valve was evaluated using echocardiography.
Results: A total of 60 patients (37 men; mean age, 62.4 years) underwent folding mitral valve repair from
January 2007 to September 2011. Of these patients, 38 (63%) had moderate and 18 (30%) had severe mitral
valve regurgitation preoperatively. Folding mitral valve repair was applied to the anterior leaflet and posterior
leaflet. The mean cardiopulmonary bypass time and crossclamp time were 148 and 90 minutes, respectively.
No patient had systolic anterior motion. Postoperative echocardiography revealed no mitral valve regurgitation
to trivial mitral valve regurgitation in 48 and mild mitral valve regurgitation in 12 patients. No patient required
reoperation for recurrent mitral valve regurgitation.
Conclusions: Folding mitral valve repair is an easily fine-tuned technique with a pilot suture, which can be easily
removed and repositioned, if unsatisfactory. This reversibility is a significant advantage of this technique. Long-
term follow-up is necessary to assess the durability of this technique. (J Thorac Cardiovasc Surg 2013;145:104-9)Mitral valve repair has several advantages over mitral valve
replacement, including lower operative mortality, improved
left ventricular function, lower freedom from reoperation
and complications related to anticoagulation, and superior
long-term survival.1-3 The Society of Thoracic Surgeons
database showed that the rate of mitral valve repair
increased from 51% in 2000 to 69% in 2007 in the
United States.4 Carpentier’s technique5 for mitral valve re-
pair, which incorporated both leaflet repair by quadrangular
resection and annuloplasty, has been the most common
technique for degenerative posterior leaflet disease. The
principles of Carpentier’s mitral valve repair include sup-
porting the leaflet tissue, eliminating tension on the leaflet
suture lines, and reinforcing the reconstruction with ane Department of Cardiovascular Surgery, Tokyo Women’s Medical Univer-
okyo, Japan.
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The Journal of Thoracic and Cardiovascular Surgannuloplasty ring. In patients requiring broad posterior leaf-
let resection, however, a very large defect needs to be cov-
ered by the thin, narrow remaining portion of the posterior
leaflet, with aggressive annuloplasty, which can cause sys-
tolic anterior motion. The sliding technique represents a so-
lution for systolic anterior motion6; however, this
technique is irrevocable and requires precise leaflet cutting
and suturing. The complexity of this procedure has been
perceived to be difficult by surgeons. Gillinov and col-
leagues1 reported 64 of 3051 patients (2.1%) had unsuc-
cessful repair that was converted to replacement during
the initial operation. Despite the several advantages of mi-
tral valve repair, Bolling and colleagues7 reported the
mean rate of mitral valve repair was 41% and the median
number of mitral valve operations annually was 5. In-
creased surgeon mitral volume was associated with an in-
creased propensity to perform mitral valve repair. For
example, for a surgeon performing 100 mitral cases annu-
ally, the risk-adjusted odds ratio for mitral valve repair was
3.78 times (95% confidence interval, 1.87-7.64) that of
a patient treated by a surgeon who performed the median
number (n ¼ 5) of mitral cases annually.7
To overcome these problems, we used the folding mitral
valve repair (FMVR) technique. This is a nonresectional
technique with inversion of the prolapsed segment into
the left ventricle and ring annuloplasty.ery c January 2013
Abbreviations and Acronyms
FMVR ¼ folding mitral valve repair
IE ¼ infectious endocarditis
MR ¼ mitral valve regurgitation
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Mitral valve surgery was indicated for patients with mitral valve regur-
gitation (MR) greater than moderate or any MR with infectious endocardi-
tis (IE). Between January 2007 and September 2011, 88 patients were
eligible for mitral valve repair for mitral valve prolapse. Of the 88 patients
with mitral valve prolapse, 60 (68.2%) underwent mitral valve repair with
the FMVR technique and 19 underwent the resection technique because of
IE or surgeon preference. The remainder underwent repair with artificial
chordae. After January 2009, the rate of FMVR increased, 53 of 60 patients
with mitral valve prolapse (88.3%) received the FMVR technique. The
pre- and postoperative data were retrospectively analyzed.
OPERATIVE TECHNIQUE
All procedures were performed through amedian sternot-
omy. The mitral valve was approached by way of a left at-
riotomy. A transseptal approach was applied to patients who
required simultaneous tricuspid valve repair. Mitral ring an-
nuloplasty sutures were placed and retracted to expose the
mitral valve. The prolapsed segment of the mitral valve
was identified with a saline pressure test (Figure 1,A). In pa-
tients with a prolapsed posterior leaflet, the prolapsed seg-
ment was inverted into the left ventricle vertically. A pilotFIGURE 1. A, Saline pressure test showing large prolapsed P1 segment with
monofilament polypropylene pilot suture. Standard quadrangular resection tech
polypropylene suture in figure-of-8 fashion was added to same segment of pro
placed toward the annulus. D, Mitral valve was reconstructed with annuloplast
coaptation.
The Journal of Thoracic and Casuture of 5-0 monofilament polypropylene was placed
vertically at the free edge of the prolapsed leaflet and tied
temporarily with a single knot (Figure 1, B). If the saline
pressure test still showed MR, the suture was removed
and repositioned. After confirming the absence of MR
with the test, the pilot suture was tied securely, and addi-
tional interrupted sutures were placed toward the annulus
(Figure 1, C). At this point, the mitral valve leaflet usually
appeared to be competent with sufficient coaptation. In pa-
tients with a prolapsed commissural leaflet, the prolapsed
segment and prolapsed posterior leaflet were inverted into
the left ventricle. In patients with a prolapsed A1 or A3 seg-
ment, a pilot suture was placed on the edge of the prolapsed
segment and brought out to the anterolateral or posterome-
dial annulus, respectively. In most cases, annuloplasty was
added to the same segment to facilitate leaflet approxima-
tion with 3-0 monofilament polypropylene suture in a figur-
e-of-8 fashion. If the test still showed MR, artificial
chordae were placed to adjust the leaflet height as needed.
A full ring, Carpentier-Edwards Physio (Edwards Life-
science, LLC, Irvine, Calif) or Carpentier-Edwards Physio
II (Edwards Lifescience, LLC), or a partial ring, Cosgrove-
Edwards (Edwards Lifescience, LLC) was placed to pre-
vent future annular dilation. The repaired mitral valve
was evaluated using transesophageal echocardiography in
the operating room and transthoracic echocardiography
before discharge.torn chordae. B, P1 segment inverted vertically into left ventricle with 5-0
nique would remove this segment. C, Annuloplasty with 3-0 monofilament
lapse, P1, to facilitate leaflet approximation and interrupted sutures were
y ring. Saline pressure test showed competent mitral valve with sufficient
rdiovascular Surgery c Volume 145, Number 1 105
TABLE 1. Patient demographics
Variable Value
Patients (n) 60
Age (y)
Mean  SD 62.4  11.1
Range 37-84
Male gender (n) 37 (61.7)
Height (cm)
Mean  SD 162.7  9.8
Range 144-189
Weight (kg)
Mean  SD 57.4  11.4
Range 35-84
Preoperative mitral valve regurgitation grade (n)
Moderate 38 (63.3)
Severe 18 (30)
Infectious endocarditis 7 (11.7); healed, 6
Ejection fraction (%)
Mean  SD 55.7  7.0
Range 33-69
Systolic pulmonary artery pressure (mm Hg)
Mean  SD 34.2  11.7
Range 17-70
Left ventricular diameter at systole (mm)
Mean  SD 36.3  7.6
Range 22-58
NYHA functional class
I 22 (36.7)
II 35 (58.3)
III 2 (3.3)
IV 1 (1.7)
Preoperative cardiogenic shock 2 (3.3)
Hypertension 34 (56.7)
Hyperlipidemia 21 (35.0)
Diabetes 5 (8.3)
Smoking 6 (10)
Creatinine level (mg/dL)
Mean  SD 1.0  1.0
Range 0.5-8.6
Total bilirubin level (mg/dL)
Mean  SD 0.8  0.4
Range 0.3-1.8
Hemodialysis 1 (1.7)
Chronic obstructive pulmonary disease 4 (6.7)
Cerebrovascular disease 1 (1.7)
Previous cardiac surgery 2 (3.3)
Urgent 2 (3.3)
(Continued)
TABLE 1. Continued
Variable Value
Prosthesis type and size
Carpentier-Edwards Physio
28 mm 4
30 mm 11
32 mm 4
Carpentier-Edwards Physio II
26 mm 2
28 mm 21
30 mm 12
32 mm 4
Cosgrove
30 mm 1
No prosthesis 1
Postoperative mitral valve regurgitation grade
None to trivial 66 (79.5)
Mild 17 (20.5)
Moderate 0
Severe 0
Data in parentheses are percentages. NYHA, New York Heart Association; SD,
standard deviation.
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DRESULTS
A total of 60 patients with mitral valve prolapse under-
went mitral valve repair with the FMVR technique. Preop-
erative echocardiography showed moderate MR in 38
(63.3%) and severe MR in 18 (30%); 7 patients (11.7%)
had IE preoperatively. However, 6 had been treated with an-
tibiotics and the IE of 1 was not well controlled before sur-
gery. Two patients (3.3%) underwent urgent surgery106 The Journal of Thoracic and Cardiovascular Surgbecause of cardiogenic shock. The perioperative data are
summarized in Table 1.
In most patients, the mitral valve was approached by way
of a left atriotomy. Of the 60 patients, 44 (73%) had pro-
lapse of a single segment, 33 of whom had posterior leaflet
prolapse (P1, 3; P2, 12; P3, 18), and 16 (27%) had prolapse
of multiple segments, including 5 with both anterior and
posterior leaflet prolapse. FMVR was applied to a single
segment in 54 patients (90%). Most FMVR was applied
to the posterior leaflet (P1, 3; P2, 14; P3, 19). Simultaneous
with FMVR, 51 patients (85%) underwent annuloplasty to
the same lesion in which FMVR was applied. Two patients
(3.3%) required multiple annuloplasties, placing more than
2 annuloplasty stitches to reduce the annular size, for the
posterior leaflet (P2þP3, 1 and P1þP2þP3, 1). The mitral
valve pathologic data and FMVR data are summarized
in Tables 2 through 4. Of the 60 patients, 59 (98.3%)
received a full or partial ring, including Carpentier-
Edwards Physio in 19 (31.7%), Carpentier-Edwards Physio
II in 39 (65%), and Cosgrove ring in 1 (1.7%). Ring selec-
tion was surgeon preference. One patient received no ring
because of active IE. This patient had vegetation at the tip
of both prolapsed leaflets. FMVR was applied after the veg-
etation had been completely removed. No ring was placed
to prevent recurrence of infection. Five patients (8.3%)
had artificial chordae placed (A1 in 1, A2 in 1, A3 in 2,
and P2 in 1). Concomitant procedures included correction
of arrhythmia in 23 (38.3%), tricuspid valve repair in 14
(23.3%), coronary artery bypass grafting in 5 (8.3%), and
aortic valve replacement in 3 (5%). The cardiopulmonary
bypass and aortic crossclamp time was 147.7  37.1 min-
utes and 89.8  27.1 minutes, respectively. Intraoperativeery c January 2013
TABLE 2. Prolapsed segment
Segment Patients (n)
Single (n ¼ 44)
A1 4 (6.7)
A2 0 (0)
A3 5 (8.3)
AC 1 (1.7)
P1 3 (5)
P2 12 (20)
P3 18 (30)
PC 1 (1.7)
Multiple (n ¼ 16)
A1, AC 1 (1.7)
A1, P1 1 (1.7)
A1, P3 1 (1.7)
A2, A3 2 (3.3)
A2, A3, AC 1 (1.7)
A2, A3, P3 1 (1.7)
A3, P3 2 (3.3)
A3, PC 3 (5)
P1, P2 1 (1.7)
P1, P2, P3 1 (1.7)
P2, P3 1 (1.7)
P3, PC 1 (1.7)
Data in parentheses are percentages. AC, Anterolateral commissure; PC, posterome-
dial commissure.
TABLE 3. Folding segment
Segment Patients (n)
Single (n ¼ 54)
A1 6 (10)
A2 0 (0)
A3 7 (11.7)
AC 1 (1.7)
P1 3 (5)
P2 14 (23.3)
P3 19 (31.7)
PC 4 (6.6)
Multiple (n ¼ 6)
A1, P1 1 (1.7)
A2, A3 1 (1.7)
A2, A3, P3 1 (1.7)
A3, PC 1 (1.7)
P2, P3 1 (1.7)
P3, PC 1 (1.7)
Data in parentheses are percentages. AC, Anterolateral commissure; PC, posterome-
dial commissure.
TABLE 4. Annuloplasty segment
Segment Patients (n)
Single (n ¼ 51)
A1 3 (5)
A2 0 (0)
A3 1 (1.7)
AC 3 (5)
P1 3 (5)
P2 13 (21.7)
P3 23 (38.3)
PC 5 (8.3)
Multiple (n ¼ 2)
P1, P2, P3 1 (1.7)
P2, P3 1 (1.7)
No annuloplasty 7 (11.7)
Data in parentheses are percentages. AC, Anterolateral commissure; PC, posterome-
dial commissure.
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had systolic anterior motion after bypass. Postoperative
transthoracic echocardiography revealed no MR to trivial
MR in 48 (80%) and mild MR in 12 (20%) before dis-
charge. All patients were discharged and were still alive
at the last follow-up visit. Follow-up transthoracic echocar-
diography was performed in 35 patients (58.3%) after
discharge (mean postoperative period, 518 days; range,
80-1763) and showed no MR to trivial MR in 18 and mild
MR in 17. No patient required reoperation for recurrent
MR.
DISCUSSION
Several simplified mitral valve repair techniques without
leaflet resection have been reported. Calafiore and col-
leagues8 plicated the posterior leaflet horizontally to the
annulus by passing ‘‘U’’ sutures from the annulus to the
midportion of the scallop to reduce the height of the pro-
lapsing myxomatous scallops. Tabata and colleagues9 and
Mihaljevic and colleagues10 also described horizontal fold-
ing valvuloplasty without leaflet resection for myxomatous
posterior mitral valve disease. They placed sutures from the
leaflet free edge to the annulus on the prolapsed or redun-
dant portion of the posterior leaflet, causing the mid-
scallop to fold under itself. Woo and MacArthur11 modified
the McGoon plication repair.12 The prolapsed posterior
leaflet was inverted vertically into the left ventricle with
a double-running CV5 polytetrafluoroethylene sutureThe Journal of Thoracic and Ca(Gore-Tex; WL Gore & Associates Inc, Flagstaff, Ariz).
These techniques were used for prolapsed posterior
leaflet only.
Our technique, FMVR, is an easily fine-tuned technique
with a pilot suture, which can be easily removed and repo-
sitioned, if unsatisfactory. This reversibility is a significant
advantage and might contribute to a greater repair rate. We
have no case that was converted to replacement during the
initial operation in the present study.
In the setting of the leaflet resection technique, putting
sutures on the remaining thin leaflet can result in leaflet tear-
ing and subsequent MR. FMVR might be able to lower this
risk, because the sutures are placed on the thickened leaflet
owing to degeneration with wider suture bites. After suc-
cessful FMVR experience with the posterior leaflet, we
have expanded the indications for FMVR to the anterior
and commissural leaflets. In cases with a prolapsedrdiovascular Surgery c Volume 145, Number 1 107
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prolapsed leaflet into the left ventricle and annuloplasty
and repair of the prolapsed posterior leaflet. In cases with
a prolapsed A1 or A3 segment, 1 arm of the suture was
placed on the free edge of the prolapsed leaflet, and the
other armwas brought out to the anterolateral or posterome-
dial annulus to invert a part of the prolapsed anterior seg-
ment. Annuloplasty was not always applied to the anterior
leaflet. As needed, artificial chordae were added to adjust
the leaflet height.
The simplicity and reproducibility of this technique make
it a potentially attractive alternative for minimally invasive,
endoscopic, and robotic mitral valve procedures. Also, the
reversibility of this technique provides a chance for resi-
dents to gain experience in mitral valve repair.
A potential risk of infection or thromboembolism exists,
related to the inverted tissue. We have had no infection or
thromboembolism to date. Anticoagulation with warfarin
(Coumadin sodium) was continued for 2 months only after
surgery unless the patient had an indication for long-term
anticoagulation.
The limitations of this repair include that it might be dif-
ficult to apply this technique to calcified leaflets. It might not
be possible to apply this technique to the A2 segment, and
artificial chordae will still be required for some cases with
a prolapsed anterior leaflet. The present studywas retrospec-
tive, and the duration of follow-up was short (<5 years). A
larger patient series and long-term follow-up are necessary
to assess the efficacy and durability of this technique.
CONCLUSIONS
FMVR is an easy technique without resection for repair
of the prolapsed mitral valve. The propalsed segment was
inverted into the left ventricle vertically with a pilot suture,
which can be easily removed and repositioned, if unsatis-
factory. This reversibility is a significant advantage of this
technique. Good short-term outcomes were observed.
This technique can also be applied to anterior leaflet patho-
logic entities in selected patients.
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Dr D. Craig Miller (Stanford, Calif). Dr Tsukui, welcome to
Hawaii and theWestern Thoracic Surgical. Very nice presentation,
paper, and video.
I have 2 comments and 2 questions. Number 1 is a comment.
This was an elegant presentation, but we must remember that
what you are calling ‘‘foldoplasty’’ is not new. It is actually
a very old technique, analogous to what Dwight McGoon pio-
neered 50 years ago at the Mayo Clinic. What you are showing
is very similar, but why are we trying to reincarnate these ancient
McGoon techniques today? TheMcGoon ‘‘V-excision’’ repair had
been abandoned everywhere, except at the Mayo Clinic, until the
last decade when it was resurrected by Tommy Mihaljevic, the
New York University group, and Larry Cohen. More recently,
Joe Woo at Pennsylvania published a repair technique very similar
to yours in the Journal of Thoracic and Cardiovascular Surgery,
which I call the ‘‘dunkoplasty,’’ where you just bury the excess
posterior scallop prolapse down inside the ventricle. The question
remains—why are some groups reincarnating these old tech-
niques? I will get to this in a minute.
A couple questions now. What is your patient follow-up magni-
tude and extent? You have been doing this for about 5 years, but I
did not see any follow-up mentioned in the paper. I did not see any
1-year or 2-year echocardiographic results, nor did I see any 1-year
or 2-year echocardiographic results. How can we judge if your ap-
proach has merit if we do not know the follow-up and at least the
short-term echocardiographic results?
Dr Tsukui. Thank you very much for your questions. As you
pointed out, this is a type ofMcGoon technique, which was already
performed before. Our concept is a little bit different from that of
Dr Cohen’s or Dr Woo’s, because our stitch is really easy to re-
move after being placed. In addition, Dr Cohen’s technique is
a horizontal technique, but our technique is vertical. The reason
we started this technique for mitral valve regurgitation is it is easier
to teach the residents. Once a resident cuts the mitral valve inap-
propriately, we cannot fix it, but if we use this technique, we can
repair the valve again after removing the pilot stitch. That is
why we started this technique.
As you pointed out, we do not have long-term outcomes yet.
The oldest one is just 4 years. Now we are examining echocardio-
graphic data for mitral valve at our outpatient clinic, and we did not
have significant mitral regurgitation (MR), as I showed here. Also,
we are checking the B-type natriuretic peptide level, whichery c January 2013
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natriuretic peptide level data today, but I would like to show you at
the next WTSA [Western Thoracic Surgical Association] annual
meeting.
Dr Miller. Okay, that is interesting, because it leads to my next
question. Because most of your patients were asymptomatic or
minimally symptomatic, New York Heart Association class I or
II preoperatively, is having 20% of patients have residual mild
MR at hospital discharge acceptable quality? I do not believe
that result will help us convince cardiologists that early repair
for asymptomatic patients is justified. You can almost get that
good a repair with an Abbott MitraClip or 2, at about
$US20,000 a pop. Is that really satisfactory surgical quality?
Dr Tsukui. This is my personal impression, but cardiologists’
evaluations are really tough for cardiac surgeons. They diagnose
even really small regurgitation as ‘‘mild’’ MR after surgery. I am
not sure, but if we do not have any progression of MR for a couple
of years after surgery, we could tell this technique is effective. We
will see in the next couple years.
Dr Miller. Good. That is what I was asking for—late echocar-
diographic results. I am surprised the B-type natriuretic peptide
levels were elevated preoperatively, because most of your patients
really did not have many symptoms. Perhaps you could put those
data in your paper when Dr Cohen gives you the chance to revise it.
This leads me to my chief comment, which is something we all
should do some soul searching about. Why are we striving to bring
back these older, simpler techniques?Was not theMcGoon ‘‘V-ex-
cision’’ judged long ago to be obsolete, except at the Mayo Clinic?
Only recently, coupled with the advent of robotic mitral surgery,
has it resurfaced and is now in vogue in Cleveland and Ranny Chit-
wood’s center in East Greenville, North Carolina? These old
methods had been jettisoned over the years and replaced by newer
resectional methods, ‘‘slidingplasty,’’ and the Gore-Tex neochord
techniques at most experienced mitral centers. Has the resurgence
of interest in ‘‘folding plasty’’ and/or simple McGoon
‘‘V-excision’’ just been due to the stampede to perform surgery
through a smaller hole or with robotic assistance? Why should
we compromise our surgical approach and our surgical outcome
standards just to do something more quickly using minimal inva-
sively approaches? This worries me. Additionally, to make the re-
pair simpler (or ‘‘dumb it down’’) so that it can be applied just to
raise the 69% national rate of repair to 90% bymore surgeons, who
do not see a lot of mitral valve cases—recall that the average num-
ber of mitral repair or replacement operations performed is only 5
per US surgeon annually—could backfire and come back to
haunt us if the results are not as good as that reported from the
high-volume centers. I tell David Adams every time I seeThe Journal of Thoracic and Cahim he is being unrealistic when he tells all of us that we must re-
pair at least 95% of regurgitant mitral valves. Marc Gillinov has
shown clearly that a good mitral replacement is much better than
a suboptimal repair. We simply cannot afford to compromise our
surgical repair outcomes. The cardiologists are lurking to jump
on this and will claim your repair results are no better than those
with a MitraClip. We must remember that our surgical goal, espe-
cially in patients with asymptomatic or minimally symptomatic
prolapse, is to have a nearly perfect repair and show our cardiolo-
gists satisfactory echocardiographic results 10 or more years later.
If we do not achieve that goal, we are not giving our patients the
best solution to their problem. I am already concerned that the re-
sults of mitral valve repair are deteriorating nationwide in the
United States; yes, more repairs are being done, but the results
might not be as good as earlier reported from high-volume mitral
institutions. If this is true, the cardiologists are going to see this as
an opportunity to do something with an intervention because our
standards have slipped to a point at which they might be able to
equal them.
In summary, we look forward to you coming back in a few years
with the 5-year echocardiographic results that will demonstrate
whether this simplified technique has merit. Congratulations on
a nice presentation. Thank you.
Dr Tsukui. Thank you.
Dr Scott McClure (Boston, Mass). Nice presentation. As Dr
Miller just alluded, at the Brigham, Dr Cohn will often use and
teach a ‘‘folding plasty’’ repair, in which he folds the posterior leaf-
let back from the free edge to the annulus. For years, Dr Sari Aranki
at the Brigham has used a repair technique that seems quite similar
towhat you have described today, in which he invaginates a portion
of the posterior leaflet downward into the left ventricular cavity.
When deciding whether to use their ‘‘folding plasty’’ repairs, Drs
Cohn and Aranki generally differentiate between those patients
who have myxomatous disease with elongated chords and those
withmyxomatous disease and ruptured chords. Barring the odd ex-
ception to the rule, they would tend to perform a leaflet resection if
they identified any major ruptured chords within the prolapsing
segment of the leaflet. My question is this: I just want to know
whether a similar distinction ismade at your center before perform-
ing a ‘‘folding plasty’’ or whether you use this technique in the
presence of both elongated and rupture chords indiscriminately?
Dr Tsukui. Thank you for the question. For the ruptured chor-
dae case, we applied the ‘‘folding plasty’’ technique first. Some-
times, as you pointed out, we still have prolapse owing to the
ruptured chordae. At that time, we place artificial chordae to
pull the prolapsed leaflet down to the left ventricle or, as you
pointed out, we cut it out, if it is really large.rdiovascular Surgery c Volume 145, Number 1 109
